Foamix Pharmaceuticals Ltd.
(NASDAQ : FOMX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
-3.37%18.371.8%$102.54m
UTHRUnited Therapeutics Corporation
-1.58%76.2914.3%$73.59m
JAZZJazz Pharmaceuticals Plc
-2.13%131.522.3%$67.53m
SAGESAGE Therapeutics, Inc.
-2.94%177.288.7%$65.80m
MDCOMedicines Company
-2.78%35.3921.8%$56.15m
ARQLArQule, Inc.
-4.48%10.020.7%$53.61m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.46%171.106.2%$51.48m
PRGOPerrigo Co. Plc
-0.90%44.106.8%$51.35m
ICPTIntercept Pharmaceuticals, Inc.
-1.72%79.9918.6%$49.31m
CTLTCatalent Inc
-0.79%52.822.4%$43.63m
HZNPHorizon Pharma plc
-1.91%23.326.7%$38.30m
ICLRICON Plc
0.42%148.264.1%$36.63m
ZYNEZynerba Pharmaceuticals Inc
-2.51%13.018.3%$28.32m
AXSMAxsome Therapeutics, Inc.
-3.19%23.402.1%$27.81m
PTLAPortola Pharmaceuticals, Inc.
-4.52%26.177.5%$26.90m

Company Profile

Foamix Pharmaceuticals Ltd. is a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.